Search results
Supplies of Wegovy and Other Weight Loss Drugs Can Now Be Tracked by Patients
Gizmodo via Yahoo News· 1 day agoAs Novo Nordisk and Eli Lilly struggle to keep up with soaring demand for their popular diabetes and...
Weight Loss Drug Market To Rocket To $130B By 2030 With Eli Lilly, Novo Nordisk In Lead...
Benzinga· 17 hours agoGoldman Sachs analysts re-rated Eli Lilly And Co LLY and Novo Nordisk A/S NVO, citing the potential...
...Nordisk (NYSE:NVO), Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM), Eli Lilly and Co (NYSE:LLY)
Benzinga· 13 hours agoThis ETF presents a unique opportunity for investors to gain exposure to the weight-loss sector...
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro
WPRI Providence· 7 days agoEli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually...
Eli Lilly is spending billions on a new facility to make its popular weight loss drug Zepbound
Quartz· 7 days agoThe new spend brings the company’s total investment in the site to a whopping $9 billion, up from...
Eli Lilly and Co., increases LEAP District investment to $9B forweight loss drug
The Indianapolis Star· 7 days agoEli Lilly and Co., is more than doubling its investment in its Boone County manufacturing site to...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 20 hours agoLilly has proposed patients stop receiving the drug once their brains are clear of beta amyloid....
Eli Lilly to spend $5.3 billion to boost Zepbound, Mounjaro manufacturing
Market Watch· 7 days agoEli Lilly & Co. said Friday that it has more than doubled its investment in a Lebanon, Ind., site to...
Eli Lilly invests $9 billion to increase supply of blockbuster drugs Zepbound and Mounjaro
USA Today· 7 days agoEli Lilly and Co., is more than doubling its investment in an Indiana manufacturing site to increase...
Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows
Reuters via AOL· 3 days agoAs millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies,...